Direct regulation of TWIST by HIF-1α promotes metastasis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Cell Biology

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb1691PMID 18297062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

  2007cited by this paper
• Hif-1α regulates differentiation of limb bud mesenchyme and joint development

  2007cited by this paper
• Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.

  2007cited by this paper
• Overexpression of NBS1 induces epithelial–mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome

  2007cited by this paper
• Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition

  2006cited by this paper
• Lysyl oxidase is essential for hypoxia-induced metastasis

  2006cited by this paper
• VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Hypoxia in head and neck cancer.

  2006cited by this paper
• Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

  2006cited by this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cited by this paper
• Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

  2006cited by this paper
• N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.

  2006cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• The transcriptional repressor Snail promotes mammary tumor recurrence.

  2005cited by this paper
• Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

  2005cited by this paper
• HIF‐1α induces cell cycle arrest by functionally counteracting Myc

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

  2004cited by this paper
• c-Myc Directly Regulates the Transcription of the NBS1 Gene Involved in DNA Double-strand Break Repair *

  2003cited by this paper
• Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

  2003cited by this paper
• Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma.

  2003cited by this paper
• Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.

  2003cited by this paper
• A Twist in fate: evolutionary comparison of Twist structure and function.

  2002cited by this paper
• HIF-1 and tumor progression: pathophysiology and therapeutics.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Hypoxia and oxidative stress in breast cancer: Hypoxia signalling pathways

  2001cited by this paper
• Patterns of Gene Expression During Drosophila Mesoderm Development

  2001cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• Caenorhabditis elegans twist plays an essential role in non-striated muscle development.

  2000cited by this paper
• Twist is a potential oncogene that inhibits apoptosis.

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

  1998cited by this paper
• HIF‐1α is required for solid tumor formation and embryonic vascularization

  1998cited by this paper
• twist is required in head mesenchyme for cranial neural tube morphogenesis.

  1995cited by this paper

• SOX11 Is Regulated by EGFR-STAT3 and Promotes Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma

  2026cites this paper
• Delivery System of Nanozymes Loaded with DNAzymes and Hypoxia-Activated Prodrug for Anti-Tumor Metastasis.

  2025cites this paper
• A near-infrared light-triggered covalent nanodrug for combined singlet oxygen therapy and photothermal therapy.

  2025cites this paper
• Single-cell transcriptomic analysis reveals metastatic and immunosuppressive characteristics in meningioma brain-tumor interface

  2025cites this paper
• Mechanisms and implications of epithelial cell plasticity in the bladder

  2025cites this paper
• UCHL1 stabilizes Twist1 via K11/K63-linked deubiquitination to drive tumor metastasis in non-small cell lung cancer

  2025cites this paper
• Brain CD73 modulates interferon signaling to regulate glioblastoma invasion

  2025cites this paper
• Cytogenetic signatures favoring metastatic organotropism in colorectal cancer

  2025cites this paper
• Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions

  2025cites this paper
• Identification, functional insights and therapeutic targeting of EMT tumour states

  2025cites this paper
• SENP1: A perspective from immune cells to disease (Review)

  2025cites this paper
• Integrative bioinformatics and experimental validation unveil CRISP3 as a hypoxia-, epithelial mesenchymal transition-, and immune-related prognostic biomarker and therapeutic target in breast cancer

  2025cites this paper
• HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment

  2025cites this paper
• Emerging strategies in engineering nanomaterials for overcoming cancer stem cell-mediated therapy resistance

  2025cites this paper
• Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review

  2025cites this paper
• Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma

  2025cites this paper
• Interplay of Metastasis, Cancer Stem Cells, and Energy Metabolism in Cancer Progression

  2025cites this paper
• Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

  2025cites this paper
• FV-429 suppresses cancer cell migration and invasion by EMT via the Hippo/YAP1 pathway in pancreatic cancer cells.

  2025cites this paper
• Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia

  2025cites this paper
• Role of Ubiquitin-regulated EMT in Cancer Metastasis and Chemoresistance

  2025cites this paper
• Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer

  2025cites this paper
• Comprehensive analysis of anosmin-1 as a potential biomarker and its correlation with epithelial–mesenchymal transition in advanced gastric cancer

  2025cites this paper
• Molecular drivers in primary brain tumor formation.

  2025cites this paper
• Upregulation of miR-200c and miR-429 Suggests Reversal Towards Epithelial State in Venous Tumour Thrombus of Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Mechanisms of Resistance to Chemotherapy in Hypopharyngeal Carcinoma

  2025cites this paper
• Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy.

  2025cites this paper
• LncRNAs in hypoxic microenvironment; insight in their impact in cancer biology

  2025cites this paper
• Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches

  2025cites this paper
• TMEM158 promotes ICC metastasis via inducing lactic acid mediated reduction of actin skeleton stiffness of ICC cells

  2025cites this paper
• Tumour hypoxia in driving genomic instability and tumour evolution

  2025cites this paper
• The regulatory role of m6A in cancer metastasis

  2025cites this paper
• Calpain 2 Isoform‐Specific Cleavage of Filamin A Enhances HIF1α Nuclear Translocation, Promoting Metastasis in Triple‐Negative Breast Cancer

  2025cites this paper
• The Novel Dual GIP and GLP‐1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism

  2025cites this paper
• Mechanosensitive Ion Channel PIEZO1 as a Key Regulator of Intestinal Fibrosis in Crohn's Disease.

  2025cites this paper
• The Oncogenic role of Lysyl Oxidase-Like 1 (LOXL1): Insights into cancer progression and therapeutic potential.

  2025cites this paper
• Rethinking metastatic brain cancer as a CNS disease.

  2025cites this paper
• Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma

  2025cites this paper
• BAP31 Promotes Epithelial–Mesenchymal Transition Progression Through the Exosomal miR-423-3p/Bim Axis in Colorectal Cancer

  2025cites this paper
• A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance

  2025cites this paper
• Hypoxia-induced genome-wide DNA demethylation by DNMT3A and EMT of cancer cells

  2025cites this paper
• Intricate relationship between cancer stemness, metastasis, and drug resistance

  2024cites this paper
• Pre-metastatic niche: formation, characteristics and therapeutic implication

  2024cites this paper
• Exploring TSGA10 Function: A Crosstalk or Controlling Mechanism in the Signaling Pathway of Carcinogenesis?

  2024cites this paper
• High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks

  2024cites this paper
• The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors

  2024cites this paper
• Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment

  2024cites this paper
• Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit

  2024cites this paper
• Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer

  2024cites this paper
• Non-canonical nuclear function of glutaminase cooperates with Wnt signaling to drive EMT during neural crest development

  2024cites this paper
• PP2A B55α Inhibits Epithelial-Mesenchymal Transition Via Regulation of Slug Expression in Non-Small Cell Lung Cancer.

  2024cites this paper
• Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWIST Axis to Inhibit EMT.

  2024cites this paper
• Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer

  2024cites this paper
• Hypoxic Memory Mediates Prolonged Tumor Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression.

  2024cites this paper
• Decoding the interplay between genetic and non-genetic drivers of metastasis

  2024cites this paper
• VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma

  2024cites this paper
• Alleviation of preeclampsia-like symptoms through PlGF and eNOS regulation by hypoxia- and NF-κB-responsive miR-214-3p deletion

  2024cites this paper
• KRT19 is regulated by miR-642a-5p and promotes pancreatic cancer progression through the Wnt/β-catenin pathway

  2024cites this paper
• The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma

  2024cites this paper
• Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors

  2024cites this paper
• The relationship between changes in peritoneal permeability with CA‐125 and HIF‐1α

  2024cites this paper
• Emerging biological functions of Twist1 in cell differentiation

  2024cites this paper
• Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities.

  2024cites this paper
• Hypoxia-induced CTCF promotes EMT in breast cancer.

  2024cites this paper
• MicroRNA-138 inhibits hypoxia-inducible factor 1α expression in breast cancer cells

  2024cites this paper
• Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation

  2024cites this paper
• The regulatory mechanisms of oncomiRs in cancer.

  2024cites this paper
• Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity

  2024cites this paper
• Associations between HIFs and tumor immune checkpoints: mechanism and therapy

  2024cites this paper
• Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.

  2024cites this paper
• The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma.

  2024cites this paper
• PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation

  2024cites this paper
• A Boolean network model of hypoxia, mechanosensing and TGF-β signaling captures the role of phenotypic plasticity and mutations in tumor metastasis

  2024cites this paper
• Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring

  2024cites this paper
• Decreased expression of TXNIP is associated with poor prognosis and immune infiltration in kidney renal clear cell carcinoma

  2024cites this paper
• Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α

  2024cites this paper
• A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis

  2024cites this paper
• Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle.

  2024cites this paper
• Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis

  2024cites this paper
• Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

  2024cites this paper
• Exploiting Transcription Factors to Target EMT and Cancer Stem Cells for Tumor Modulation and Therapy.

  2024cites this paper
• Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge

  2024cites this paper
• Cancer spreading patterns based on epithelial-mesenchymal plasticity

  2024cites this paper
• Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics

  2024cites this paper
• Coenzyme Q0 inhibited the NLRP3 inflammasome, metastasis/EMT, and Warburg effect by suppressing hypoxia-induced HIF-1α expression in HNSCC cells

  2024cites this paper
• Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment

  2024cites this paper
• Redox regulation of cancer stem cells: Biology and therapeutic implications

  2024cites this paper
• Berberine and Lung Cancer: From Pure Form to Its Nanoformulations

  2024cites this paper
• Research progress in tumor angiogenesis and drug resistance in breast cancer

  2024cites this paper
• Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance

  2024cites this paper
• Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis

  2024cites this paper
• miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer

  2024cites this paper
• Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process

  2024cites this paper
• Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines

  2024cites this paper
• Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers.

  2024cites this paper
• Antrodia salmonea suppresses epithelial-mesenchymal transition/metastasis and Warburg effects by inhibiting Twist and HIF-1α expression in Twist-overexpressing head and neck squamous cell carcinoma cells.

  2023cites this paper
• A photothermal driven chemotherapy for the treatment of metastatic melanoma.

  2023cites this paper
• Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma

  2023cites this paper
• Systematic analysis of histone acetylation regulators across human cancers

  2023cites this paper